๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nanchang
Clinical trial register · China

Clinical Trials in Nanchang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Nanchang 14
Narrow the registerReset
Recruitment status
Phase
Site location
Nanchang14
All 1 locations
Target enrolment
to

Trials with a site in Nanchang

14 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Therapeutic Effect of Bifidobacterium Longum in Patients with Acute Pancreatitis: a Randomized, Double-Blind, Placebo-Controlled Trial
NCT06639516Acute Pancreatitis
The First Affiliated Hospital of Nanchang University
Not applicable
60
Nanchang
2025-02-15
Active, closed
Efficacy and Safety of Robotic-assisted Bronchoscopy Combined With the ICNVA Strategy in Biopsy of Peripheral Pulmonary Nodules
NCT07136961Lung Nodules, Biopsy, Navigation, Spatial
The First Affiliated Hospital of Nanchang University
Not applicable
30
Nanchang
2024-12-28
Recruiting
A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma
NCT06999031Relapsed/Refractory, Multiple Myeloma
The First Affiliated Hospital of Nanchang University
Phase EARLY_PHASE1
12
Nanchang
2024-09-05
Recruiting
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
NCT06752057Advanced NSCLC
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
Recruiting
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NCT06751966Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
Recruiting
Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NCT06751953Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
Recruiting
Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751940Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
Recruiting
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751914Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
Recruiting
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
NCT06752044Advanced NSCLC
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
Recruiting
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
NCT06751849Advanced NSCLC
The First Affiliated Hospital of Nanchang University
Phase 2
10
Nanchang
2024-03-11
Recruiting
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
NCT06751901Advanced NSCLC
The First Affiliated Hospital of Nanchang University
Phase 2
10
Nanchang
2024-03-11
Not yet open
Exploring the Mechanism of Severe Acute Pancreatitis Based on Metagenomics, Metabolomics and Proteomics
NCT06230432Acute Pancreatitis
The First Affiliated Hospital of Nanchang University
Observational
176
Nanchang
2024-01-21
Recruiting
Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
NCT06118762Metastatic Colorectal Cancer
The First Affiliated Hospital of Nanchang University
Phase 4
30
Nanchang
2023-10-20
Recruiting
Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors
NCT05749627Advanced Malignant Solid Tumors
The First Affiliated Hospital of Nanchang University
Not applicable
20
Nanchang
2023-04-01
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/nanchang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Nanchang that also match the filters currently applied.

How many clinical trials are recruiting in Nanchang?

11 of the 14 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nanchang), 14 studies
PhaseStudiesRecruitingShare
Not applicable9764.3%
Phase 22214.3%
Observational107.1%
Phase 4117.1%
Phase EARLY_PHASE1117.1%

Most active sponsors

Lead sponsors with the most studies (Nanchang)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of Nanchang University1411
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.